Company Description
The Pennant Group, Inc. is a holding company, which engages in the provision of healthcare services to patients of all ages. It operates through the following segments: Home Health and Hospice Services, Senior Living Services, and All Other. The Home Health and Hospice Services segment provides comb...
The Pennant Group, Inc. is a holding company, which engages in the provision of healthcare services to patients of all ages. It operates through the following segments: Home Health and Hospice Services, Senior Living Services, and All Other. The Home Health and Hospice Services segment provides combination of clinical care services such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services. The Senior Living Services segment deals with assisted and independent living and memory care businesses. The All Other segment includes general and administrative expense from the service center. The company was founded on January 24, 2019 and is headquartered in Eagle, ID.
Valuation
P/E Current
56.16
P/E Ratio (with extraordinary items)
49.86
P/E Ratio (without extraordinary items)
49.84
Price to Sales Ratio
0.70
Price to Book Ratio
2.69
Price to Cash Flow Ratio
36.35
Enterprise Value to EBITDA
27.25
Enterprise Value to Sales
1.43
Total Debt to Enterprise Value
0.49
Efficiency
Revenue/Employee
88,705.00
Income Per Employee
1,245.00
Receivables Turnover
8.82
Total Asset Turnover
0.78
Liquidity
Current Ratio
1.05
Quick Ratio
1.05
Cash Ratio
0.03
Profitability
Gross Margin
11.34
Operating Margin
4.33
Pretax Margin
1.88
Net Margin
1.40
Return on Assets
1.10
Return on Equity
5.75
Return on Total Capital
4.45
Return on Invested Capital
1.51
Capital Structure
Total Debt to Total Equity
269.86
Total Debt to Total Capital
72.96
Total Debt to Total Assets
55.12
Long-Term Debt to Equity
256.12
Long-Term Debt to Total Capital
69.25
Officers and Executives
| Name | Age | Officer Since | Title |
|---|---|---|---|
| Mr. John J. Gochnour | 37 | 2019 | Chief Operating Officer |
| Mr. Brent Guerisoli | - | 2012 | President |
| Ms. Jennifer L. Freeman | 52 | 2019 | Chief Financial Officer |
| Mr. Barry Morgan Smith | 66 | 2021 | Independent Director |
Insider Actions
| 04/19/2023 |
JoAnne Stringfield Director |
95 | Disposition at $12.45 per share. | 1,182 |
| 04/18/2023 |
Christopher R. Christensen Director |
1,500 | Award at $0 per share. | 0 |
| 04/18/2023 |
John G. Nackel Director |
1,500 | Award at $0 per share. | 0 |
| 04/18/2023 |
Barry Morgan Smith Director |
1,500 | Award at $0 per share. | 0 |
| 04/18/2023 |
Scott E. Lamb Director |
1,500 | Award at $0 per share. | 0 |
| 04/18/2023 |
Stephen M. R. Covey Director |
1,500 | Award at $0 per share. | 0 |
| 04/18/2023 |
JoAnne Stringfield Director |
1,500 | Award at $0 per share. | 0 |
| 04/18/2023 |
Gregory K. Morris Director |
1,500 | Award at $0 per share. | 0 |
| 04/18/2023 |
JoAnne Stringfield Director |
190 | Disposition at $13.31 per share. | 2,528 |
| 03/06/2023 |
Barry Morgan Smith Director |
25,536 | Acquisition at $15 per share. | 383,040 |
| 03/03/2023 |
Barry Morgan Smith Director |
4,464 | Acquisition at $14.95 per share. | 66,736 |
| 01/19/2023 |
JoAnne Stringfield Director |
95 | Disposition at $11.37 per share. | 1,080 |
| 01/18/2023 |
JoAnne Stringfield Director |
95 | Disposition at $10.96 per share. | 1,041 |
| 01/17/2023 |
Christopher R. Christensen Director |
4,500 | Award at $0 per share. | 0 |
| 01/17/2023 |
John G. Nackel Director |
4,500 | Award at $0 per share. | 0 |
| 01/17/2023 |
Barry Morgan Smith Director |
4,500 | Award at $0 per share. | 0 |
| 01/17/2023 |
Scott E. Lamb Director |
4,500 | Award at $0 per share. | 0 |
| 01/17/2023 |
Stephen M. R. Covey Director |
4,500 | Award at $0 per share. | 0 |
| 01/17/2023 |
JoAnne Stringfield Director |
4,500 | Award at $0 per share. | 0 |
| 01/17/2023 |
Gregory K. Morris Director |
4,500 | Award at $0 per share. | 0 |
| 12/28/2022 |
Daniel H. Walker Director |
7,593 | Gift at $0 per share. | 0 |
| 12/02/2022 |
Derek J. Bunker Chief Investment Officer |
9,429 | Derivative/Non-derivative trans. at $10.52 per share. | 99,193 |
| 12/02/2022 |
Derek J. Bunker Chief Investment Officer |
6,286 | Derivative/Non-derivative trans. at $10.52 per share. | 66,128 |
| 11/30/2022 |
John G. Nackel Director |
20,000 | Acquisition at $10.13 per share. | 202,600 |
MarketWatch News on PNTG
-
Pennant Group upgraded to buy from hold at Stifel Nicolaus
- Tomi Kilgore
-
Pennant Group stock price target cut to $12 from $18 at Stifel Nicolaus
- Tomi Kilgore
-
Pennant Group stock price target cut $17 from $25 at Truist
- Tomi Kilgore
-
Pennant Group started at buy with $37 stock price target at Stifel Nicolaus
- Tomi Kilgore
-
Pennant Group price target lowered to $35 from $44 at Truist Securities, stock rated hold
- Tonya Garcia
-
Pennant Group stock price target raised to $40 from $25 at Truist
- Tomi Kilgore
-
Pennant Group started at hold with $28 stock price target at SunTrust RH
- Tomi Kilgore
Other News on PNTG
-
The Pennant Group, Inc. (PNTG) Q3 2022 Earnings Call Transcript
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
